Table 3.
Antimicrobial | Susceptibility rates % |
---|---|
Ceftazidime | 0 |
Cefepime | 0 |
Piperacillin-tazobactam | 0 |
Imipenem | 0 |
Meropenem | 43.8 |
Gentamicin | 53.8 |
Amikacin | 53.8 |
Ciprofloxacin | 0 |
Levofloxacin | 5 |
Trimethoprim-sulfamethoxazole | 8.8 |
Antimicrobial | Susceptibility rates % |
---|---|
Ceftazidime | 0 |
Cefepime | 0 |
Piperacillin-tazobactam | 0 |
Imipenem | 0 |
Meropenem | 43.8 |
Gentamicin | 53.8 |
Amikacin | 53.8 |
Ciprofloxacin | 0 |
Levofloxacin | 5 |
Trimethoprim-sulfamethoxazole | 8.8 |